|
US3687808A
(en)
|
1969-08-14 |
1972-08-29 |
Univ Leland Stanford Junior |
Synthetic polynucleotides
|
|
US4109496A
(en)
|
1977-12-20 |
1978-08-29 |
Norris Industries |
Trapped key mechanism
|
|
US4323546A
(en)
|
1978-05-22 |
1982-04-06 |
Nuc Med Inc. |
Method and composition for cancer detection in humans
|
|
US4411990A
(en)
|
1979-06-13 |
1983-10-25 |
University Patents, Inc. |
Primary bioassay of human tumor stem cells
|
|
US4873191A
(en)
|
1981-06-12 |
1989-10-10 |
Ohio University |
Genetic transformation of zygotes
|
|
US4612282A
(en)
|
1981-12-15 |
1986-09-16 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Monoclonal antibodies reactive with human breast cancer
|
|
US4670393A
(en)
|
1982-03-22 |
1987-06-02 |
Genentech, Inc. |
DNA vectors encoding a novel human growth hormone-variant protein
|
|
US5019497A
(en)
|
1984-11-09 |
1991-05-28 |
Lennart Olsson |
Human squamous lung carcinoma cell specific antigens and antibodies
|
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US5080891A
(en)
|
1987-08-03 |
1992-01-14 |
Ddi Pharmaceuticals, Inc. |
Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
|
|
US5087570A
(en)
|
1988-05-10 |
1992-02-11 |
Weissman Irving L |
Homogeneous mammalian hematopoietic stem cell composition
|
|
US4981785A
(en)
|
1988-06-06 |
1991-01-01 |
Ventrex Laboratories, Inc. |
Apparatus and method for performing immunoassays
|
|
US4968103A
(en)
|
1988-07-22 |
1990-11-06 |
Photofinish Cosmetics Inc. |
Method of making a brush
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5994617A
(en)
|
1988-09-19 |
1999-11-30 |
Hsc Research Development Corporation |
Engraftment of immune-deficient mice with human cells
|
|
US5750373A
(en)
|
1990-12-03 |
1998-05-12 |
Genentech, Inc. |
Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
|
|
US5534617A
(en)
|
1988-10-28 |
1996-07-09 |
Genentech, Inc. |
Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
|
|
US5688666A
(en)
|
1988-10-28 |
1997-11-18 |
Genentech, Inc. |
Growth hormone variants with altered binding properties
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
GB8901778D0
(en)
|
1989-01-27 |
1989-03-15 |
Univ Court Of The University O |
Manipulatory technique
|
|
US6583115B1
(en)
|
1989-10-12 |
2003-06-24 |
Ohio University/Edison Biotechnology Institute |
Methods for treating acromegaly and giantism with growth hormone antagonists
|
|
US5061620A
(en)
|
1990-03-30 |
1991-10-29 |
Systemix, Inc. |
Human hematopoietic stem cell
|
|
US5614396A
(en)
|
1990-06-14 |
1997-03-25 |
Baylor College Of Medicine |
Methods for the genetic modification of endogenous genes in animal cells by homologous recombination
|
|
US5602240A
(en)
|
1990-07-27 |
1997-02-11 |
Ciba Geigy Ag. |
Backbone modified oligonucleotide analogs
|
|
US5489677A
(en)
|
1990-07-27 |
1996-02-06 |
Isis Pharmaceuticals, Inc. |
Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms
|
|
IE20030749A1
(en)
|
1991-05-03 |
2003-11-12 |
Indiana University Foundation |
Human notch and delta binding domains in torporythmic proteins, and methods based thereon
|
|
US5856441A
(en)
|
1991-05-03 |
1999-01-05 |
Yale University |
Serrate fragments and derivatives
|
|
IL101728A
(en)
|
1991-05-03 |
2007-08-19 |
Univ Yale |
Human Abandonment and Delta, Restrictive Areas of Effect in Tophoric Proteins, and Methods Based on Them
|
|
US6429186B1
(en)
|
1991-05-10 |
2002-08-06 |
Genentech, Inc. |
Ligand antagonists for treatment of breast cancer
|
|
US5714331A
(en)
|
1991-05-24 |
1998-02-03 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
|
|
US5719262A
(en)
|
1993-11-22 |
1998-02-17 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having amino acid side chains
|
|
US5539082A
(en)
|
1993-04-26 |
1996-07-23 |
Nielsen; Peter E. |
Peptide nucleic acids
|
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
US5750376A
(en)
|
1991-07-08 |
1998-05-12 |
Neurospheres Holdings Ltd. |
In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
|
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
US5753229A
(en)
|
1991-09-25 |
1998-05-19 |
Mordoh; Jose |
Monoclonal antibodies reactive with tumor proliferating cells
|
|
US6353150B1
(en)
|
1991-11-22 |
2002-03-05 |
Hsc Research And Development Limited Partnership |
Chimeric mammals with human hematopoietic cells
|
|
US5869282A
(en)
|
1991-12-11 |
1999-02-09 |
Imperial Cancer Research Technology, Ltd. |
Nucleotide and protein sequences of the serrate gene and methods based thereon
|
|
US6004924A
(en)
|
1991-12-11 |
1999-12-21 |
Imperial Cancer Research Technology, Ltd. |
Protein sequences of serrate gene products
|
|
EP0552108B1
(en)
|
1992-01-17 |
1999-11-10 |
Lakowicz, Joseph R. |
Energy transfer phase-modulation fluoro-immunoassay
|
|
US5376313A
(en)
|
1992-03-27 |
1994-12-27 |
Abbott Laboratories |
Injection molding a plastic assay cuvette having low birefringence
|
|
US5786158A
(en)
|
1992-04-30 |
1998-07-28 |
Yale University |
Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
|
|
US5849553A
(en)
|
1992-07-27 |
1998-12-15 |
California Institute Of Technology |
Mammalian multipotent neural stem cells
|
|
US5589376A
(en)
|
1992-07-27 |
1996-12-31 |
California Institute Of Technology |
Mammalian neural crest stem cells
|
|
US5693482A
(en)
|
1992-07-27 |
1997-12-02 |
California Institute Of Technology |
Neural chest stem cell assay
|
|
CA2140884A1
(en)
|
1992-07-27 |
1994-02-03 |
David J. Anderson |
Mammalian multipotent neural stem cells
|
|
US5654183A
(en)
|
1992-07-27 |
1997-08-05 |
California Institute Of Technology |
Genetically engineered mammalian neural crest stem cells
|
|
EP1362913B1
(en)
|
1992-10-30 |
2006-01-25 |
The General Hospital Corporation |
Interaction trap system for isolating proteins
|
|
GB9223084D0
(en)
|
1992-11-04 |
1992-12-16 |
Imp Cancer Res Tech |
Compounds to target cells
|
|
JP3106021B2
(ja)
|
1992-11-30 |
2000-11-06 |
キヤノン株式会社 |
パターンデータの圧縮方法及び装置と出力方法及び装置
|
|
ES2142934T3
(es)
|
1993-02-19 |
2000-05-01 |
Nippon Shinyaku Co Ltd |
Derivado del glicerol, dispositivo y composicion farmaceutica.
|
|
US5639606A
(en)
|
1993-04-06 |
1997-06-17 |
The University Of Rochester |
Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction
|
|
US5876978A
(en)
|
1993-04-06 |
1999-03-02 |
Medical College Of Ohio |
Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction
|
|
US5643765A
(en)
|
1993-04-06 |
1997-07-01 |
University Of Rochester |
Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction
|
|
US5538848A
(en)
|
1994-11-16 |
1996-07-23 |
Applied Biosystems Division, Perkin-Elmer Corp. |
Method for detecting nucleic acid amplification using self-quenching fluorescence probe
|
|
US5599677A
(en)
|
1993-12-29 |
1997-02-04 |
Abbott Laboratories |
Immunoassays for prostate specific antigen
|
|
JP3816518B2
(ja)
|
1994-06-10 |
2006-08-30 |
ジェンベク、インコーポレイティッド |
相補的なアデノウイルスベクター系と細胞系
|
|
US6156305A
(en)
|
1994-07-08 |
2000-12-05 |
Baxter International Inc. |
Implanted tumor cells for the prevention and treatment of cancer
|
|
US5650317A
(en)
|
1994-09-16 |
1997-07-22 |
Michigan State University |
Human breast epithelial cell type with stem cell and luminal epithelial cell characteristics
|
|
CA2203809C
(en)
|
1994-10-28 |
2008-06-03 |
James M. Wilson |
Recombinant adenovirus and methods of use thereof
|
|
US6218166B1
(en)
|
1994-12-09 |
2001-04-17 |
John Wayne Cancer Institute |
Adjuvant incorporation into antigen carrying cells: compositions and methods
|
|
US5736396A
(en)
|
1995-01-24 |
1998-04-07 |
Case Western Reserve University |
Lineage-directed induction of human mesenchymal stem cell differentiation
|
|
US5872154A
(en)
|
1995-02-24 |
1999-02-16 |
The Trustees Of The University Of Pennsylvania |
Method of reducing an immune response to a recombinant adenovirus
|
|
US6207147B1
(en)
|
1996-10-11 |
2001-03-27 |
The Regents Of The University Of California |
Cancer immunotherapy using tumor cells combined with mixed lymphocytes
|
|
US5707618A
(en)
|
1995-03-24 |
1998-01-13 |
Genzyme Corporation |
Adenovirus vectors for gene therapy
|
|
US5633161A
(en)
|
1995-03-29 |
1997-05-27 |
Millennium Pharmaceuticals, Inc. |
Murine gene fomy030 coding for tumor progression inhibitor
|
|
US5821108A
(en)
|
1995-04-07 |
1998-10-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enrichment for a thymocyte subset having progenitor cell activity using c-kit as a selection marker
|
|
US5739277A
(en)
|
1995-04-14 |
1998-04-14 |
Genentech Inc. |
Altered polypeptides with increased half-life
|
|
US6019978A
(en)
|
1995-06-05 |
2000-02-01 |
The Wistar Institute Of Anatomy And Biology |
Replication-defective adenovirus human type 5 recombinant as a vaccine carrier
|
|
IL122614A0
(en)
|
1995-06-15 |
1998-08-16 |
Introgene Bv |
Packaging systems for human recombinant adenovirus to be used in gene therapy
|
|
US6117985A
(en)
|
1995-06-16 |
2000-09-12 |
Stemcell Technologies Inc. |
Antibody compositions for preparing enriched cell preparations
|
|
EP0861261B9
(en)
|
1995-06-28 |
2010-02-24 |
Imperial Cancer Research Technology Limited |
Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
|
|
EP0851925B1
(en)
|
1995-09-21 |
2005-08-03 |
Genentech, Inc. |
Human growth hormone variants
|
|
US5780300A
(en)
|
1995-09-29 |
1998-07-14 |
Yale University |
Manipulation of non-terminally differentiated cells using the notch pathway
|
|
US5986170A
(en)
|
1995-11-13 |
1999-11-16 |
Corixa Corporation |
Murine model for human carcinoma
|
|
US6337387B1
(en)
|
1995-11-17 |
2002-01-08 |
Asahi Kasei Kabushiki Kaisha |
Differentiation-suppressive polypeptide
|
|
CA2239957A1
(en)
|
1995-12-22 |
1997-07-03 |
Abbott Laboratories |
Fluorescence polarization immunoassay diagnostic method
|
|
US5994316A
(en)
|
1996-02-21 |
1999-11-30 |
The Immune Response Corporation |
Method of preparing polynucleotide-carrier complexes for delivery to cells
|
|
JP2000515364A
(ja)
|
1996-03-30 |
2000-11-21 |
サイエンス パーク ラフ ソチエタ ペル アツィオニ |
標識した活性化腫瘍特異的ｔ細胞の生産方法および腫瘍療法におけるそれらの使用
|
|
US5753506A
(en)
|
1996-05-23 |
1998-05-19 |
Cns Stem Cell Technology, Inc. |
Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals
|
|
WO1997045143A1
(en)
|
1996-05-31 |
1997-12-04 |
The National American Red Cross |
Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
|
|
US6716974B1
(en)
|
1996-05-31 |
2004-04-06 |
Maine Medical Center Research Institute |
Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
|
|
US5885529A
(en)
|
1996-06-28 |
1999-03-23 |
Dpc Cirrus, Inc. |
Automated immunoassay analyzer
|
|
FR2751986B1
(fr)
|
1996-08-01 |
1998-12-31 |
Inst Nat Sante Rech Med |
Gene implique dans le cadasil, methode de diagnostic et application therapeutique
|
|
AU723836B2
(en)
|
1996-08-29 |
2000-09-07 |
Regents Of The University Of California, The |
Kuz, a novel family of metalloproteases
|
|
WO1998013493A2
(en)
|
1996-09-24 |
1998-04-02 |
Lxr Biotechnology, Inc. |
A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
|
|
US5994132A
(en)
|
1996-10-23 |
1999-11-30 |
University Of Michigan |
Adenovirus vectors
|
|
EP0950067B1
(en)
|
1996-11-27 |
2007-08-29 |
Genentech, Inc. |
Affinity purification of polypeptide on protein a matrix
|
|
US5859535A
(en)
|
1997-02-12 |
1999-01-12 |
The United States Of America As Represented By The Secretary Of The Navy |
System for determining size and location of defects in material by use of microwave radiation
|
|
DE69837839T2
(de)
|
1997-03-07 |
2007-12-13 |
Clare Chemical Research LLC, Denver |
Fluorometrischer Nachweis mit sichtbarem Light
|
|
US6080912A
(en)
|
1997-03-20 |
2000-06-27 |
Wisconsin Alumni Research Foundation |
Methods for creating transgenic animals
|
|
US5861832A
(en)
|
1997-03-27 |
1999-01-19 |
Lucent Technologies Inc. |
Analog-to-digital converter having amplifier and comparator stages
|
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6121045A
(en)
|
1997-04-04 |
2000-09-19 |
Millennium Biotherapeutics, Inc. |
Human Delta3 nucleic acid molecules
|
|
ATE342358T1
(de)
|
1997-04-04 |
2006-11-15 |
Millennium Biotherapeutics Inc |
Neue menschliche delta3-zusammensetzung und deren therapeutische und diagnostische verwendungen
|
|
US20030180784A1
(en)
|
1997-04-04 |
2003-09-25 |
Millennium Pharmaceuticals, Inc. |
Novel human Delta3 compositions and therapeutic and diagnostic uses therefor
|
|
US5830730A
(en)
|
1997-05-08 |
1998-11-03 |
The Regents Of The University Of California |
Enhanced adenovirus-assisted transfection composition and method
|
|
ES2284205T3
(es)
|
1997-05-14 |
2007-11-01 |
Asahi Kasei Kabushiki Kaisha |
Nuevo inhibidor de diferenciacion.
|
|
US6379925B1
(en)
|
1997-06-18 |
2002-04-30 |
The Trustees Of Columbia University In The City Of New York |
Angiogenic modulation by notch signal transduction
|
|
AU8162898A
(en)
|
1997-06-18 |
1999-01-04 |
Trustees Of Columbia University In The City Of New York, The |
Angiogenic modulation by notch signal transduction
|
|
US6136952A
(en)
|
1997-06-25 |
2000-10-24 |
University Of Washington |
Human jagged polypeptide, encoding nucleic acids and methods of use
|
|
CA2290736A1
(en)
|
1997-07-11 |
1999-01-21 |
Introgene B.V. |
Interleukin-3 gene therapy for cancer
|
|
US6004528A
(en)
|
1997-09-18 |
1999-12-21 |
Bergstein; Ivan |
Methods of cancer diagnosis and therapy targeted against the cancer stemline
|
|
US7361336B1
(en)
|
1997-09-18 |
2008-04-22 |
Ivan Bergstein |
Methods of cancer therapy targeted against a cancer stem line
|
|
US6197523B1
(en)
|
1997-11-24 |
2001-03-06 |
Robert A. Levine |
Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
US6551795B1
(en)
*
|
1998-02-18 |
2003-04-22 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
|
|
US5981225A
(en)
|
1998-04-16 |
1999-11-09 |
Baylor College Of Medicine |
Gene transfer vector, recombinant adenovirus particles containing the same, method for producing the same and method of use of the same
|
|
US6252050B1
(en)
|
1998-06-12 |
2001-06-26 |
Genentech, Inc. |
Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
|
|
EP1100899A2
(en)
|
1998-07-27 |
2001-05-23 |
Amgen Inc. |
Delta-related polypeptides
|
|
EP1109896A4
(en)
|
1998-08-14 |
2005-11-02 |
Aventis Pharm Prod Inc |
ADENOVIRUS FORMULATIONS FOR GENE THERAPY
|
|
EP1108047A1
(en)
|
1998-08-27 |
2001-06-20 |
Aventis Pharma S.A. |
Targeted adenovirus vectors for delivery of heterologous genes
|
|
GB9819681D0
(en)
|
1998-09-09 |
1998-11-04 |
Smithkline Beecham Plc |
Novel compounds
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
EP1133519B1
(en)
|
1998-11-02 |
2008-08-13 |
Curis, Inc. |
Functional antagonists of hedgehog activity
|
|
US6291516B1
(en)
|
1999-01-13 |
2001-09-18 |
Curis, Inc. |
Regulators of the hedgehog pathway, compositions and uses related thereto
|
|
US20030003572A1
(en)
|
1999-03-05 |
2003-01-02 |
David J. Anderson |
Isolation and enrichment of neural stem cells from uncultured tissue based on cell-surface marker expression
|
|
US20030119029A1
(en)
|
1999-04-30 |
2003-06-26 |
Regents Of The University Of Michigan |
Compositions and methods relating to novel benzodiazepine compounds and targets thereof
|
|
WO2000073337A1
(en)
|
1999-06-01 |
2000-12-07 |
Biogen, Inc. |
Polymer conjugates of hedgehog proteins and uses
|
|
AU6069300A
(en)
|
1999-07-02 |
2001-01-22 |
Chiron Corporation |
Novel human genes and gene expression products
|
|
US6703221B1
(en)
|
1999-08-19 |
2004-03-09 |
Chiron Corporation |
Notch receptor ligands and uses thereof
|
|
WO2001022920A2
(en)
*
|
1999-09-29 |
2001-04-05 |
Human Genome Sciences, Inc. |
Colon and colon cancer associated polynucleotides and polypeptides
|
|
AU1194501A
(en)
|
1999-10-14 |
2001-04-23 |
Wistar Institute, The |
Inhibition of tumorigenic properties of melanoma cells
|
|
US6380362B1
(en)
|
1999-12-23 |
2002-04-30 |
Genesis Research & Development Corporation Ltd. |
Polynucleotides, polypeptides expressed by the polynucleotides and methods for their use
|
|
US20040048249A1
(en)
|
2000-01-21 |
2004-03-11 |
Tang Y. Tom |
Novel nucleic acids and secreted polypeptides
|
|
EP1254108A1
(en)
|
2000-01-24 |
2002-11-06 |
MERCK SHARP & DOHME LTD. |
Gamma-secretase inhibitors
|
|
US7091321B2
(en)
|
2000-02-11 |
2006-08-15 |
Emd Lexigen Research Center Corp. |
Enhancing the circulating half-life of antibody-based fusion proteins
|
|
US7115653B2
(en)
|
2000-03-30 |
2006-10-03 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
AU2001268513A1
(en)
|
2000-06-17 |
2002-01-02 |
Third Wave Technologies, Inc. |
Nucleic acid accessible hybridization sites
|
|
WO2001098354A2
(en)
|
2000-06-21 |
2001-12-27 |
Incyte Genomics, Inc. |
Human receptors
|
|
US6632620B1
(en)
|
2000-06-22 |
2003-10-14 |
Andrew N. Makarovskiy |
Compositions for identification and isolation of stem cells
|
|
DE10031380A1
(de)
|
2000-06-28 |
2002-01-10 |
Merck Patent Gmbh |
Verfahren zur Übertragung von Alkyliden-Gruppen auf organischen Verbindungen
|
|
GB0016681D0
(en)
|
2000-07-06 |
2000-08-23 |
Merck Sharp & Dohme |
Therapeutic compounds
|
|
AU2001278076A1
(en)
|
2000-07-26 |
2002-02-05 |
Applied Genomics, Inc. |
Bstp-5 proteins and related reagents and methods of use thereof
|
|
US20050089518A1
(en)
|
2001-12-07 |
2005-04-28 |
Clarke Michael F. |
Prospective identification and characterization of breast cancer stem cells
|
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
AU2001288628A1
(en)
|
2000-08-31 |
2002-03-13 |
Loyola University Chicago |
Method and reagents for treatment of skin disorders by modulating the notch pathway
|
|
US6689744B2
(en)
|
2000-09-22 |
2004-02-10 |
Genentech, Inc. |
Notch receptor agonists and uses
|
|
ATE431851T1
(de)
|
2000-12-13 |
2009-06-15 |
Anaphore Inc |
Methode zur identifikation und isolation von peptide die andere moleküle binden aus kombinatorische proteinbibliotheken mit einer c- typ lectin-ähnlichen domäne als gerüststruktur
|
|
US20020169300A1
(en)
|
2001-01-30 |
2002-11-14 |
Waterman Marian L. |
Method of detection and treatment of colon cancer by analysis of beta-catenin-sensitive isoforms of lymphoid enhancer factor-1
|
|
US7413873B2
(en)
|
2001-01-30 |
2008-08-19 |
The Regents Of The University Of California |
Method of detection and treatment of colon cancer
|
|
US20030064384A1
(en)
|
2001-04-02 |
2003-04-03 |
Mien-Chie Hung |
Beta-catenin is a strong and independent prognostic factor for cancer
|
|
IL142481A0
(en)
|
2001-04-05 |
2002-03-10 |
Yissum Res Dev Co |
A method for identifying consitutively active mutants of mitogen activated protein kinases (mapk) and uses thereof
|
|
ATE484522T1
(de)
|
2001-04-24 |
2010-10-15 |
Bayer Corp |
Menschliche antikörper gegen timp-1
|
|
WO2002088081A2
(en)
|
2001-05-01 |
2002-11-07 |
The Regents Of The University Of California |
Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
|
|
US7713526B2
(en)
|
2001-05-01 |
2010-05-11 |
The Regents Of The University Of California |
Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
|
|
US20030044409A1
(en)
|
2001-05-01 |
2003-03-06 |
Carson Dennis A. |
Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens
|
|
US7514594B2
(en)
|
2001-05-11 |
2009-04-07 |
Wyeth |
Transgenic animal model of bone mass modulation
|
|
JP2005500303A
(ja)
|
2001-06-15 |
2005-01-06 |
ジェネンテック・インコーポレーテッド |
ヒト成長ホルモンアンタゴニスト
|
|
US7171311B2
(en)
|
2001-06-18 |
2007-01-30 |
Rosetta Inpharmatics Llc |
Methods of assigning treatment to breast cancer patients
|
|
US20040023244A1
(en)
|
2001-06-21 |
2004-02-05 |
Griffin Jennifer A |
Receptors
|
|
EP1956078A3
(en)
|
2001-06-22 |
2008-10-29 |
StemCells, Inc. |
Liver engrafting cells, assays, and uses thereof
|
|
WO2003000893A2
(en)
|
2001-06-26 |
2003-01-03 |
Decode Genetics Ehf. |
Nucleic acids encoding g protein-coupled receptors
|
|
DE60113733T2
(de)
|
2001-07-02 |
2006-06-29 |
Tas, Sinan |
Verwendung von cyclopamine, zur behandlung des basalzellkarzinoms und anderer tumoren
|
|
CA2452152A1
(en)
|
2001-07-02 |
2002-10-10 |
Sinan Tas |
Use of cyclopamine in the treatment of psoriasis
|
|
WO2003004045A2
(en)
|
2001-07-05 |
2003-01-16 |
Xenon Genetics, Inc. |
Methods for identifying therapeutic agents for treating diseases involving wnt polypeptides and wnt receptors
|
|
AU2002365066A1
(en)
|
2001-07-18 |
2003-07-09 |
American Red Cross |
Mutant proteinase inhibitors and uses thereof
|
|
JP2004538324A
(ja)
|
2001-08-03 |
2004-12-24 |
メディカル リサーチ カウンシル |
細胞内抗体
|
|
MXPA04001014A
(es)
|
2001-08-03 |
2004-05-27 |
Schering Corp |
Novedosos inhibidores de la gama secretasa.
|
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
|
JP2005526701A
(ja)
|
2001-11-14 |
2005-09-08 |
ロランティス リミテッド |
内科療法
|
|
US7053547B2
(en)
|
2001-11-29 |
2006-05-30 |
Universal Display Corporation |
Increased emission efficiency in organic light-emitting devices on high-index substrates
|
|
US20070237770A1
(en)
|
2001-11-30 |
2007-10-11 |
Albert Lai |
Novel compositions and methods in cancer
|
|
PL372144A1
(en)
|
2001-12-26 |
2005-07-11 |
Immunomedics, Inc. |
Methods of generating multispecific, multivalent agents from v sb h /sb and v sb l /sb domains
|
|
US6713206B2
(en)
|
2002-01-14 |
2004-03-30 |
Board Of Trustees Of University Of Illinois |
Electrochemical cells comprising laminar flow induced dynamic conducting interfaces, electronic devices comprising such cells, and methods employing same
|
|
GB0201674D0
(en)
|
2002-01-25 |
2002-03-13 |
Lorantis Ltd |
Medical treatment
|
|
US20030185829A1
(en)
|
2002-03-12 |
2003-10-02 |
Erich Koller |
Jagged 2 inhibitors for inducing apoptosis
|
|
CA2492671C
(en)
|
2002-03-22 |
2012-04-17 |
Aprogen, Inc. |
Humanized antibody and process for preparing same
|
|
WO2003092630A2
(en)
|
2002-05-06 |
2003-11-13 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries
|
|
WO2003099781A2
(en)
|
2002-05-24 |
2003-12-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES
|
|
JP2005530856A
(ja)
|
2002-06-21 |
2005-10-13 |
ジョンズ ホプキンス ユニバーシティー スクール オブ メディシン |
膜関連腫瘍内皮マーカー
|
|
WO2004020668A2
(en)
|
2002-08-30 |
2004-03-11 |
Oncotherapy Science, Inc. |
Method for treating synovial sarcoma
|
|
US7803370B2
(en)
|
2002-08-30 |
2010-09-28 |
Oncotherapy Science, Inc. |
Method for treating synovial sarcoma
|
|
GB0221952D0
(en)
|
2002-09-20 |
2002-10-30 |
Novartis Forschungsstiftung |
Wnt mediated ErbB1 signalling,compositions and uses related thereto
|
|
US20040058217A1
(en)
|
2002-09-20 |
2004-03-25 |
Ohlsen Leroy J. |
Fuel cell systems having internal multistream laminar flow
|
|
CA2501235A1
(en)
|
2002-10-04 |
2004-04-22 |
The Regents Of The University Of California |
Methods for treating cancer by inhibiting wnt signaling
|
|
JP2006508682A
(ja)
|
2002-12-06 |
2006-03-16 |
ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ |
β−カテニンシグナル伝達経路の調節による細胞傷害剤からの幹細胞の保護
|
|
US7803783B2
(en)
|
2002-12-06 |
2010-09-28 |
The Board Of Trustees Of The Leland Stanford Junior University |
Use of WNT inhibitors to augment therapeutic index of chemotherapy
|
|
US20040219579A1
(en)
|
2003-02-19 |
2004-11-04 |
Natasha Aziz |
Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
WO2005005601A2
(en)
|
2003-06-09 |
2005-01-20 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
ES2381841T3
(es)
|
2003-07-11 |
2012-06-01 |
Oncotherapy Science, Inc. |
Método para tratar el sarcoma sinovial
|
|
WO2005031003A1
(en)
|
2003-09-22 |
2005-04-07 |
The Regents Of The University Of California |
Mutations in wnt-frizzled signaling pathways associated with osteoarthritis
|
|
US6894522B2
(en)
|
2003-10-06 |
2005-05-17 |
International Business Machines Corporation |
Specific site backside underlaying and micromasking method for electrical characterization of semiconductor devices
|
|
AU2005248351A1
(en)
|
2004-05-14 |
2005-12-08 |
The Regents Of The University Of California |
Methods for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA
|
|
WO2006036175A2
(en)
|
2004-09-21 |
2006-04-06 |
Rhode Island Hospital, A Lifespan-Partner |
Wnt proteins and detection and treatment of cancer
|
|
CA2580803C
(en)
|
2004-09-21 |
2016-06-14 |
Rhode Island Hospital, A Lifespan-Partner |
Wnt proteins and detection and treatment of cancer
|
|
WO2006036179A2
(en)
|
2004-09-21 |
2006-04-06 |
Rhode Island Hospital, A Lifespan-Partner |
Frizzled proteins and detection and treatment of cancer
|
|
CA2580796C
(en)
|
2004-09-24 |
2013-03-26 |
Amgen Inc. |
Modified fc molecules having peptides inserted in internal loop regions
|
|
DE102004050620A1
(de)
|
2004-10-13 |
2006-04-20 |
Eberhard-Karls-Universität Tübingen |
Monoklonaler Antikörper gegen Frizzled-Rezeptoren
|
|
US8809287B2
(en)
|
2004-11-15 |
2014-08-19 |
Icahn School Of Medicine At Mount Sinai |
Compositions and methods for altering Wnt autocrine signaling
|
|
EP1817427B1
(en)
|
2004-11-24 |
2010-09-08 |
F. Hoffmann-La Roche AG |
Method for determining genotoxicity
|
|
US7635530B2
(en)
|
2005-03-21 |
2009-12-22 |
The Board Of Trustees Of The University Of Illinois |
Membraneless electrochemical cell and microfluidic device without pH constraint
|
|
EP1902318A1
(en)
|
2005-05-30 |
2008-03-26 |
AstraZeneca AB |
Methods for identifying fzd8 modulators and the use of such modulators for treating osteoarthritis
|
|
US20070014776A1
(en)
*
|
2005-06-09 |
2007-01-18 |
Gimeno Ruth E |
Identification of adiponutrin-related proteins as esterases and methods of use for the same
|
|
US20070072239A1
(en)
*
|
2005-09-26 |
2007-03-29 |
Wyeth |
Pharmaceutical compositions and methods of using secreted frizzled related protein
|
|
DK1931697T3
(da)
|
2005-09-28 |
2010-11-08 |
Zymogenetics Inc |
IL-17A og IL-17F-antagonister og fremgangsmåder til anvendelse af disse
|
|
ES2547421T3
(es)
|
2005-10-31 |
2015-10-06 |
Oncomed Pharmaceuticals, Inc. |
Composiciones y métodos para diagnosticar y tratar el cáncer
|
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
DOP2006000277A
(es)
|
2005-12-12 |
2007-08-31 |
Bayer Pharmaceuticals Corp |
Anticuerpos anti mn y métodos para su utilización
|
|
AR060017A1
(es)
|
2006-01-13 |
2008-05-21 |
Novartis Ag |
Composiciones y metodos de uso para anticuerpos de dickkopf -1
|
|
US20080171319A1
(en)
|
2006-02-06 |
2008-07-17 |
Mickey Urdea |
Osteoporosis associated markers and methods of use thereof
|
|
GB0603683D0
(en)
|
2006-02-23 |
2006-04-05 |
Novartis Ag |
Organic compounds
|
|
WO2007134876A2
(en)
|
2006-05-24 |
2007-11-29 |
Bayer Schering Pharma Aktiengesellschaft |
HIGH AFFINITY HUMAN AND HUMANIZED ANTI-α5β1 INTEGRIN FUNCTION BLOCKING ANTIBODIES WITH REDUCED IMMUNOGENICITY
|
|
CA2655289C
(en)
|
2006-06-21 |
2016-08-23 |
Oncotherapy Science, Inc. |
Tumor-targeting monoclonal antibodies to fzd10 and uses thereof
|
|
TW200815469A
(en)
|
2006-06-23 |
2008-04-01 |
Astrazeneca Ab |
Compounds
|
|
EP2079484A4
(en)
|
2006-09-07 |
2010-03-17 |
Stemline Therapeutics Inc |
MONITORING OF CANCER STEM CELLS
|
|
CN101600449A
(zh)
*
|
2006-09-08 |
2009-12-09 |
健泰科生物技术公司 |
Wnt拮抗剂及其在wnt介导的病症的诊断和治疗中的用途
|
|
PE20081217A1
(es)
*
|
2006-09-08 |
2008-09-24 |
Genentech Inc |
Antagonistas del gen wnt y su uso en el diagnostico y tratamiento de trastornos mediados por el wnt
|
|
WO2008039071A2
(en)
|
2006-09-29 |
2008-04-03 |
Agendia B.V. |
High-throughput diagnostic testing using arrays
|
|
US20100041102A1
(en)
|
2006-11-07 |
2010-02-18 |
Ayesha Sitlani |
Antagonists of pcsk9
|
|
KR20090080082A
(ko)
|
2006-11-14 |
2009-07-23 |
노파르티스 아게 |
암을 치료, 진단 또는 검출하는 방법
|
|
KR101541935B1
(ko)
|
2007-09-26 |
2015-08-05 |
인트렉손 코포레이션 |
합성 5'ｕｔｒ, 발현 벡터, 및 전이유전자 발현의 증가방법
|
|
AR068767A1
(es)
|
2007-10-12 |
2009-12-02 |
Novartis Ag |
Anticuerpos contra esclerostina, composiciones y metodos de uso de estos anticuerpos para tratar un trastorno patologico mediado por esclerostina
|
|
WO2009118300A1
(en)
|
2008-03-25 |
2009-10-01 |
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
Treating cancer by down-regulating frizzled-4 and/or frizzled-1
|
|
DE202008004821U1
(de)
|
2008-04-07 |
2008-06-12 |
Heil, Roland |
Siebdruckform
|
|
RU2010145972A
(ru)
*
|
2008-04-11 |
2012-05-20 |
СиБАЙО ЛИМИТЕД (AU) |
МОДИФИЦИРОВАННЫЙ Cpn10 И ПЕРЕДАЧА СИГНАЛА PRR
|
|
FR2936255B1
(fr)
|
2008-09-19 |
2010-10-15 |
Galderma Res & Dev |
Modulateurs de fzd2 dans le traitement de l'alopecie
|
|
KR101711672B1
(ko)
|
2008-09-26 |
2017-03-03 |
온코메드 파마슈티칼스, 인크. |
프리즐드 결합 작용제 및 그의 용도
|
|
US20130295106A1
(en)
|
2008-09-26 |
2013-11-07 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-Binding Agents And Uses Thereof
|
|
JP5727226B2
(ja)
|
2008-09-30 |
2015-06-03 |
協和発酵キリン株式会社 |
Ｆｒｉｚｚｌｅｄ１、Ｆｒｉｚｚｌｅｄ２又はＦｒｉｚｚｌｅｄ７細胞外システインリッチドメインを含む蛋白質を含有する骨疾患治療用医薬組成物
|
|
US20100169025A1
(en)
|
2008-10-10 |
2010-07-01 |
Arthur William T |
Methods and gene expression signature for wnt/b-catenin signaling pathway
|
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Ｗｎｔ拮抗劑及治療和篩選方法
|
|
UY33227A
(es)
|
2010-02-19 |
2011-09-30 |
Novartis Ag |
Compuestos de pirrolopirimidina como inhibidores de la cdk4/6
|
|
EP2545187B1
(en)
|
2010-03-09 |
2018-09-05 |
Dana-Farber Cancer Institute, Inc. |
Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy
|
|
CA2794674A1
(en)
|
2010-04-01 |
2011-10-06 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
|
EP2585098B1
(en)
|
2010-06-28 |
2014-08-27 |
Five Prime Therapeutics, Inc. |
Fzd8 extracellular domains and fzd8 extracellular domain fusion molecules for use in treating obesity and obesity-related disorders
|
|
UY33469A
(es)
|
2010-06-29 |
2012-01-31 |
Irm Llc Y Novartis Ag |
Composiciones y metodos para modular la via de señalizacion de wnt
|
|
CA2815181C
(en)
|
2010-10-27 |
2020-09-15 |
William Gleason Richards |
Dkk1 antibodies and methods of use
|
|
AU2013334790A1
(en)
|
2012-10-23 |
2015-04-30 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using Wnt pathway-binding agents
|
|
WO2014121196A1
(en)
|
2013-02-04 |
2014-08-07 |
Oncomed Pharmaceuticals, Inc. |
Methods and monitoring of treatment with a wnt pathway inhibitor
|